Cargando…
Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study
Menopausal Hormone Therapy (MHT) use in Australia fell by 55% from 2001 to 2005, following the release of large-scale findings on its risks and benefits. Comprehensive national data, including information on overall prevalence of MHT use as well as information on duration of use in Australia have no...
Autores principales: | Velentzis, Louiza S., Banks, Emily, Sitas, Freddy, Salagame, Usha, Tan, Eng Hooi, Canfell, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805183/ https://www.ncbi.nlm.nih.gov/pubmed/27008039 http://dx.doi.org/10.1371/journal.pone.0146494 |
Ejemplares similares
-
Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations
por: Velentzis, Louiza S., et al.
Publicado: (2017) -
Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study
por: Velentzis, Louiza S., et al.
Publicado: (2021) -
Bioidentical Hormones for Menopausal Hormone Therapy: Variation on a Theme
por: Fugh-Berman, Adriane, et al.
Publicado: (2007) -
Defining bioidentical hormones for menopause-related symptoms
por: Whelan, Anne Marie, et al.
Publicado: (2011) -
Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause
por: Yap, Sarsha, et al.
Publicado: (2022)